Sanofi (SNY) Non Operating Income (2009 - 2016)
Sanofi's (SNY) quarterly Non Operating Income came in at -$430.8 million in Q4 2016, down 3.16% year-over-year from -$444.9 million in Q1 2016, and down 231.0% quarter-over-quarter from -$130.2 million in Q1 2016.
Analysis
Sanofi (SNY) Non Operating Income (2009 - 2016) Analysis & Trends
Sanofi has disclosed Non Operating Income across 8 years of filings, most recently posting -$430.8 million for Q4 2016.
- In Q4 2016, Non Operating Income fell 3.16% year-over-year to -$430.8 million; the TTM figure through Dec 2016 stood at -$1.1 billion (down 42.67% YoY), while the FY2015 annual figure was -$433.2 million, up 27.09% from the prior year.
- Non Operating Income came in at -$430.8 million for Q4 2016 at Sanofi, down from -$130.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of -$104.1 million in Q1 2014 to a low of -$430.8 million in Q4 2016.
- Average Non Operating Income over 5 years is -$213.1 million, with a median of -$175.7 million recorded in 2013.
- Year-over-year, Non Operating Income slumped 176.77% in 2012 and soared 54.25% in 2014.
- Over 5 years, Non Operating Income stood at -$421.5 million in 2012, then gained by 10.55% to -$377.0 million in 2013, then surged by 54.25% to -$172.5 million in 2014, then slumped by 142.13% to -$417.6 million in 2015, then slipped by 3.16% to -$430.8 million in 2016.
- Per Business Quant data, the three most recent Non Operating Income figures were -$430.8 million in Q4 2016, -$130.2 million in Q1 2016, and -$417.6 million in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | -139.24 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -430.81 Mn |
| Mar 31, 2016 | -130.16 Mn |
| Dec 31, 2015 | -417.62 Mn |
| Sep 30, 2015 | -116.79 Mn |
| Jun 30, 2015 | -123.78 Mn |
| Mar 31, 2015 | -109.59 Mn |
| Dec 31, 2014 | -172.48 Mn |
| Sep 30, 2014 | -184.49 Mn |
| Jun 30, 2014 | -128.96 Mn |
| Mar 31, 2014 | -104.15 Mn |
| Dec 31, 2013 | -377.02 Mn |
| Sep 30, 2013 | -162.98 Mn |
| Jun 30, 2013 | -178.89 Mn |
| Mar 31, 2013 | -184.85 Mn |
| Dec 31, 2012 | -421.49 Mn |
| Sep 30, 2012 | -168.83 Mn |
| Jun 30, 2012 | -200.45 Mn |
| Mar 31, 2012 | -221.61 Mn |
| Dec 31, 2011 | -152.29 Mn |
| Sep 30, 2011 | -171.17 Mn |